» Articles » PMID: 26823697

Mixed Group of Rhizobiales Microbes in Lung and Blood of a Patient with Fatal Pulmonary Illness

Overview
Specialty Pathology
Date 2016 Jan 30
PMID 26823697
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the microbial composition in the diseased lung and early-phase microbial cultures from the blood of a patient with a rapidly progressing fatal pulmonary illness. Although no microbes could be isolated from such cultures during the initial study, the HTS-microbiome study revealed the presence of a unique mixture of alphaproteobacteria, composed mainly of different families of Rhizobiales microbes. Microbial 16S rDNA sequences matching closely to Afipia cberi were identified mainly in the patient's diseased lung tissue, but only rarely in the early-phase blood cultures. Conversely, the high abundance of sequences found in early-phase blood cultures of different broth media matched closely with those of the families Methylobacteriaceae, Phyllobacteriaceae and Sphingomonadaceae. The two species that successfully adapted to grow in a laboratory culture system were A. cberi and Mesorhizobium hominis, which eventually were isolated from a previously cryopreserved blood culture of SP4 broth. Many other species, including members of the Bradyrhizobiaceae and Phyllobacteriaceae families, and all members of the Methylobacteriaceae and Sphingomonadaceae families identified by HTS remained non-cultivated. We developed specific PCR primers and FISH probes, which detected the target Rhizobiales microbes in former blood cultures and autopsy lung tissues. It is unclear what role these Rhizobiales microbes might have played in the patient's complex disease process. However, the above mentioned assays should help in rapidly detecting and identifying these previously unrecognized Rhizobiales microbes in patients.

Citing Articles

16S rDNA analysis of the effect of fecal microbiota transplantation on pulmonary and intestinal flora.

Liu T, Yang Z, Zhang X, Han N, Yuan J, Cheng Y 3 Biotech. 2017; 7(6):370.

PMID: 29071167 PMC: 5639806. DOI: 10.1007/s13205-017-0997-x.


Bacterial microbiome in the nose of healthy cats and in cats with nasal disease.

Dorn E, Tress B, Suchodolski J, Nisar T, Ravindran P, Weber K PLoS One. 2017; 12(6):e0180299.

PMID: 28662139 PMC: 5491177. DOI: 10.1371/journal.pone.0180299.


Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method - the observation of DNAemia.

Gosiewski T, Ludwig-Galezowska A, Huminska K, Sroka-Oleksiak A, Radkowski P, Salamon D Eur J Clin Microbiol Infect Dis. 2016; 36(2):329-336.

PMID: 27771780 PMC: 5253159. DOI: 10.1007/s10096-016-2805-7.


The Hoops, Hopes, and Hypes of Human Microbiome Research.

Bik E Yale J Biol Med. 2016; 89(3):363-373.

PMID: 27698620 PMC: 5045145.

References
1.
Huson D, Mitra S, Ruscheweyh H, Weber N, Schuster S . Integrative analysis of environmental sequences using MEGAN4. Genome Res. 2011; 21(9):1552-60. PMC: 3166839. DOI: 10.1101/gr.120618.111. View

2.
Biesecker L . Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project. Genet Med. 2012; 14(4):393-8. PMC: 3790899. DOI: 10.1038/gim.2011.78. View

3.
Caporaso J, Lauber C, Walters W, Berg-Lyons D, Huntley J, Fierer N . Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012; 6(8):1621-4. PMC: 3400413. DOI: 10.1038/ismej.2012.8. View

4.
Morgan X, Huttenhower C . Chapter 12: Human microbiome analysis. PLoS Comput Biol. 2013; 8(12):e1002808. PMC: 3531975. DOI: 10.1371/journal.pcbi.1002808. View

5.
Lo S, Hung G, Li B, Lei H, Li T, Nagamine K . Isolation of novel Afipia septicemium and identification of previously unknown bacteria Bradyrhizobium sp. OHSU_III from blood of patients with poorly defined illnesses. PLoS One. 2013; 8(10):e76142. PMC: 3796525. DOI: 10.1371/journal.pone.0076142. View